nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Allogeneic Hematopoietic Cell Transplantation in Patients With Myelodysplastic Syndromes
|
Platzbecker, Uwe |
|
2012 |
49 |
4 |
p. 342-349 8 p. |
artikel |
2 |
Clinical Results With the DNA Hypomethylating Agent 5-Aza-2′-Deoxycytidine (Decitabine) in Patients With Myelodysplastic Syndromes: An Update
|
Joeckel, Tina E. |
|
2012 |
49 |
4 |
p. 330-341 12 p. |
artikel |
3 |
Cover
|
|
|
2012 |
49 |
4 |
p. OFC- 1 p. |
artikel |
4 |
Erratum
|
|
|
2012 |
49 |
4 |
p. 361- 1 p. |
artikel |
5 |
Erratum
|
|
|
2012 |
49 |
4 |
p. 361- 1 p. |
artikel |
6 |
Future Issues and Recent Issues
|
|
|
2012 |
49 |
4 |
p. A3- 1 p. |
artikel |
7 |
Immunomodulatory Treatment of Myelodysplastic Syndromes: Antithymocyte Globulin, Cyclosporine, and Alemtuzumab
|
Parikh, Ankur R. |
|
2012 |
49 |
4 |
p. 304-311 8 p. |
artikel |
8 |
Introduction: Application of New Therapies to Myelodysplastic Syndrome
|
Giagounidis, Aristoteles |
|
2012 |
49 |
4 |
p. 285-286 2 p. |
artikel |
9 |
Lenalidomide for del(5q) and Non-del(5q) Myelodysplastic Syndromes
|
Giagounidis, Aristoteles A.N. |
|
2012 |
49 |
4 |
p. 312-322 11 p. |
artikel |
10 |
Masthead
|
|
|
2012 |
49 |
4 |
p. IFC- 1 p. |
artikel |
11 |
Overview of Myelodysplastic Syndromes
|
Beris, Photis |
|
2012 |
49 |
4 |
p. 287-294 8 p. |
artikel |
12 |
Previous Issues
|
|
|
2012 |
49 |
4 |
p. A2- 1 p. |
artikel |
13 |
Table of Contents
|
|
|
2012 |
49 |
4 |
p. A1- 1 p. |
artikel |
14 |
The Non-transplant Treatment of Myelodysplastic Syndromes—What's on the Horizon?
|
Kulasekararaj, Austin G. |
|
2012 |
49 |
4 |
p. 350-360 11 p. |
artikel |
15 |
Treatment of Advanced Myelodysplastic Syndrome With Demethylating Agents: Azacitidine
|
Adès, Lionel |
|
2012 |
49 |
4 |
p. 323-329 7 p. |
artikel |
16 |
Treatment of Low-Risk Myelodysplastic Syndrome: Hematopoietic Growth Factors Erythropoietins and Thrombopoietins
|
Santini, Valeria |
|
2012 |
49 |
4 |
p. 295-303 9 p. |
artikel |